- Home
- SNDX vs PSFE Comparison
SNDX vs PSFE Comparison
Compare SNDX & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- PSFE
- Stock Information
- Founded
- SNDX 2005
- PSFE 1996
- Country
- SNDX United States
- PSFE United Kingdom
- Employees
- SNDX N/A
- PSFE N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- PSFE Business Services
- Sector
- SNDX Health Care
- PSFE Consumer Discretionary
- Exchange
- SNDX Nasdaq
- PSFE Nasdaq
- Market Cap
- SNDX 1.2B
- PSFE 1.1B
- IPO Year
- SNDX 2016
- PSFE N/A
- Fundamental
- Price
- SNDX $14.63
- PSFE $19.90
- Analyst Decision
- SNDX Strong Buy
- PSFE Sell
- Analyst Count
- SNDX 10
- PSFE 4
- Target Price
- SNDX $36.20
- PSFE $19.50
- AVG Volume (30 Days)
- SNDX 2.1M
- PSFE 216.7K
- Earning Date
- SNDX 02-25-2025
- PSFE 03-06-2025
- Dividend Yield
- SNDX N/A
- PSFE N/A
- EPS Growth
- SNDX N/A
- PSFE N/A
- EPS
- SNDX N/A
- PSFE N/A
- Revenue
- SNDX $16,000,000.00
- PSFE $1,699,306,000.00
- Revenue This Year
- SNDX N/A
- PSFE $9.73
- Revenue Next Year
- SNDX N/A
- PSFE $7.00
- P/E Ratio
- SNDX N/A
- PSFE N/A
- Revenue Growth
- SNDX N/A
- PSFE 8.22
- 52 Week Low
- SNDX $12.06
- PSFE $11.94
- 52 Week High
- SNDX $25.34
- PSFE $26.25
- Technical
- Relative Strength Index (RSI)
- SNDX 57.25
- PSFE 67.11
- Support Level
- SNDX $13.61
- PSFE $18.66
- Resistance Level
- SNDX $14.62
- PSFE $19.00
- Average True Range (ATR)
- SNDX 0.62
- PSFE 0.57
- MACD
- SNDX 0.15
- PSFE 0.21
- Stochastic Oscillator
- SNDX 91.20
- PSFE 97.21
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet, and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.